Treatment of gastrointestinal cytomegalovirus infection with twice-daily foscarnet: a pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS.

Por Dieterich, D T, Poles, M A, Lew, E A, Martin-Munley, S, Johnson, J, Nix, D, Faust, M J
Publicado em 1997

Effect of Ribavirin on Intracellular and Plasma Pharmacokinetics of Nucleoside Reverse Transcriptase Inhibitors in Patients with Human Immunodeficiency Virus-Hepatitis C Virus Coin...

Por Rodriguez-Torres, M., Torriani, F. J., Soriano, V., Borucki, M. J., Lissen, E., Sulkowski, M., Dieterich, D., Wang, K., Gries, J.-M., Hoggard, P. G., Back, D.
Publicado em 2005

Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir

Por Bichoupan, K., Schwartz, J. M., Martel-Laferriere, V., Giannattasio, E. R., Marfo, K., Odin, J. A., Liu, L. U., Schiano, T. D., Perumalswami, P., Bansal, M., Gaglio, P. J., Kalia, H., Dieterich, D. T., Branch, A. D., Reinus, J. F.
Publicado em 2013